New vaccine schedule tested to protect babies from pneumococcal disease
NCT ID NCT06824181
Summary
This study is testing whether a new 21-valent pneumococcal vaccine is safe and helps babies build immunity when given after one or more doses of an existing 20-valent vaccine. It will involve about 580 healthy infants and toddlers, who will receive the vaccines as part of their routine childhood shots over about 19 months. The main goal is to see if mixing these vaccines in different schedules works as well as using only the licensed vaccine.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PNEUMOCOCCAL IMMUNIZATION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Atlantis Clinical Research- Site Number : 8400009
Miami, Florida, 33173, United States
-
Carolina Family Care - Charleston- Site Number : 8400014
Charleston, South Carolina, 29414, United States
-
Clinsearch Inc at Dr. Gala, LLC- Site Number : 8400027
Miami, Florida, 33135, United States
-
Clinsearch Inc at VAST Clinical Research- Site Number : 8400028
Euless, Texas, 76040, United States
-
DM Clinical Research - Houston - Jones Road- Site Number : 8400012
Houston, Texas, 77065, United States
-
Finger Lakes Medical Research - Cortland- Site Number : 8400022
Cortland, New York, 13045, United States
-
Helios Clinical Research - BUR PEDI- Site Number : 8400016
Burleson, Texas, 76028, United States
-
Investigational Site Number : 1520001
Santiago, Reg Metropolitana de Santiago, 8880465, Chile
-
Investigational Site Number : 1520002
Santiago, Reg Metropolitana de Santiago, 8380418, Chile
-
Investigational Site Number : 1520003
Santiago, Reg Metropolitana de Santiago, 8330034, Chile
-
Investigational Site Number : 4840001
Mexico City, Mexico City, 04530, Mexico
-
Investigational Site Number : 4840002
Temixco, Morelos, 62587, Mexico
-
Investigational Site Number : 4840003
León, Guanajuato, 37320, Mexico
-
Investigational Site Number : 4840004
Tlaltizapán, Morelos, 62770, Mexico
-
Investigational Site Number : 6080001
Cebu City, 6000, Philippines
-
Investigational Site Number : 6080002
Quezon City, 1100, Philippines
-
Investigational Site Number : 6080003
Quezon City, 1121, Philippines
-
Javara - Privia Medical Group North Texas - Stephenville- Site Number : 8400024
Stephenville, Texas, 76401, United States
-
Kaiser Permanente - Los Angeles Medical Center- Site Number : 8400025
Los Angeles, California, 90027, United States
-
Kid's Way Pediatrics- Site Number : 8400013
Hermitage, Pennsylvania, 16148, United States
-
Private Practice - Dr. Michael W. Simon- Site Number : 8400001
Lexington, Kentucky, 40517, United States
-
SUNY Upstate Medical University - Syracuse- Site Number : 8400015
Syracuse, New York, 13210, United States
-
The Medici Medical Research- Site Number : 8400008
Hollywood, Florida, 33021, United States
-
University of Rochester Medical Center- Site Number : 8400019
Rochester, New York, 14642, United States
-
University of Texas Medical Branch at Galveston- Site Number : 8400005
League City, Texas, 77555, United States
-
Velocity Clinical Research - New Orleans- Site Number : 8400006
New Orleans, Louisiana, 70119, United States
-
Velocity Clinical Research - Sioux City- Site Number : 8400007
Sioux City, Iowa, 51106, United States
Conditions
Explore the condition pages connected to this study.